Xconomy’s Digital Events →
Ian Schofield has been writing on issues affecting the pharmaceutical and biotech industry since the mid-1980s. He writes for Scrip and Pink Sheet and can be contacted at [email protected]
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing... Read more »
Sponsored · Whitepaper
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.